http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011101771-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate | 2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011101771-A |
| titleOfInvention | PEDIATRIC COMPOSITIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS |
| abstract | 1. A pharmaceutical composition comprising a 2-amino-2- [2- (4-C2-C20 alkylphenyl) ethyl] propane-1,3-diol derivative or a pharmaceutically acceptable salt thereof in an amount of about 1.25 mg or less, which is intended to treat, prevent or slow the development of multiple sclerosis in a patient, where the composition is for oral administration and where the patient is a patient of pediatric age. ! 2. The composition according to claim 1, containing the compound in an amount of 0.5 mg or less. ! 3. The composition according to claim 1 or 2, where the patient's age is from 10 to 18 years. ! 4. The composition according to claim 1 or 2, where the patient's age is from 11 to 16 years. ! 5. The use of a derivative of 2-amino-2- [2- (4-C2-C20 alkylphenyl) ethyl] propane-1,3-diol or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment, prevention or delay of the development of multiple sclerosis patient, where the drug is intended for oral administration and where the patient is a patient of pediatric age. ! 6. A package containing a pharmaceutical composition that contains a derivative of 2-amino-2- [2- (4-C2-C20 alkylphenyl) ethyl] propan-1,3-diol or a pharmaceutically acceptable salt thereof in an amount of about 1.25, 0.5 mg or less, and a label with instructions for using the composition for treating, preventing or slowing the development of multiple sclerosis in a patient, wherein the composition is for oral administration and the patient is a patient of pediatric age. ! 7. A method for treating, preventing or slowing the development of multiple sclerosis in a patient |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2549899-C2 |
| priorityDate | 2008-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.